OnKure Therapeutics, Inc.(OKUR) - 2025 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 80301 (Zip Code) (Registrant's telephone number, including area code): (720) 307-2892 Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading symbol | Na ...